Ergocalciferol in Chronic Kidney Disease

NCT00411294 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2006-12-13

No results posted yet for this study

Summary

To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4

Conditions

Sponsors & Collaborators

  • Saint Louis VA Medical Center

    lead FED

Principal Investigators

  • Ziyad Al-Aly, M.D. · VAMC-Saint Louis

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00411294 on ClinicalTrials.gov